Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Weight loss with interferon and ribavirin therapy in chronic hepatitis C patients.

Sajjad SF, Ahmed Wu, Arif A, Alam SE, Waquar J.

J Pak Med Assoc. 2012 Nov;62(11):1229-32.

PMID:
23866417
[PubMed - indexed for MEDLINE]
3.

Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C*.

Seyam MS, Freshwater DA, O'Donnell K, Mutimer DJ.

J Viral Hepat. 2005 Sep;12(5):531-5.

PMID:
16108770
[PubMed - indexed for MEDLINE]
4.

The burden of HCV treatment in patients with inherited bleeding disorders.

Fransen van de Putte DE, Fischer K, Posthouwer D, Mauser-Bunschoten EP.

Haemophilia. 2011 Sep;17(5):791-9. doi: 10.1111/j.1365-2516.2011.02602.x. Epub 2011 Jun 21.

PMID:
21689211
[PubMed - indexed for MEDLINE]
5.

Evaluation of prognostic factors for Peg Interferon alfa-2b plus ribavirin treatment on HCV infected patients in Pakistan.

Aziz H, Gil ML, Waheed Y, Adeeb U, Raza A, Bilal I, Athar MA.

Infect Genet Evol. 2011 Apr;11(3):640-5. doi: 10.1016/j.meegid.2011.01.022. Epub 2011 Feb 18.

PMID:
21316487
[PubMed - indexed for MEDLINE]
6.

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, Zeuzem S, Craxi A, Ling MH, Albrecht J.

N Engl J Med. 1998 Nov 19;339(21):1493-9.

PMID:
9819447
[PubMed - indexed for MEDLINE]
Free Article
7.

Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.

Alsaran K, Sabry A, Shaheen N.

Int Urol Nephrol. 2011 Sep;43(3):865-73. doi: 10.1007/s11255-010-9756-1. Epub 2010 May 19.

PMID:
20490669
[PubMed - indexed for MEDLINE]
8.

Effects of host and virus related factors on interferon-α+ribavirin and pegylated-interferon+ribavirin treatment outcomes in chronic Hepatitis C patients.

Akram M, Idrees M, Zafar S, Hussain A, Butt S, Afzal S, Rehman IU, Liaqat A, Saleem S, Ali M, Butt A.

Virol J. 2011 May 17;8:234. doi: 10.1186/1743-422X-8-234.

PMID:
21575275
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Comparative study of the efficacy of an induction dose of interferon-alpha2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C.

Pérez R, Jiménez M, Crespo J, Diago M, Enríquez J, Vaquero P, Solá R, Olcoz JL, Romero M, Salmerón J, Blanco MI, Oña M, Melón S, Rodrigo L; Grupo Inter-Hospitalario Español.

J Viral Hepat. 2003 Nov;10(6):437-45.

PMID:
14633177
[PubMed - indexed for MEDLINE]
10.

Chronic cough associated with interferon/ribavirin therapy for hepatitis C.

Dicpinigaitis PV, Weiner FR.

J Clin Pharm Ther. 2011 Jun;36(3):416-8. doi: 10.1111/j.1365-2710.2010.01182.x. Epub 2010 Sep 30.

PMID:
21545621
[PubMed - indexed for MEDLINE]
11.

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK.

N Engl J Med. 1998 Nov 19;339(21):1485-92.

PMID:
9819446
[PubMed - indexed for MEDLINE]
Free Article
12.

Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.

Böcher WO, Schuchmann M, Link R, Hillenbrand H, Rahman F, Sprinzl M, Mudter J, Löhr HF, Galle PR.

Liver Int. 2006 Apr;26(3):319-25.

PMID:
16584394
[PubMed - indexed for MEDLINE]
13.

Adverse effects of peg-Interferon and Ribavirin combined antiviral treatment in a Romanian hepatitis C virus infected cohort.

Predescu O, Streba LA, Irimia E, Streba L, Mogoantă L.

Rom J Morphol Embryol. 2012;53(3):497-502.

PMID:
23010773
[PubMed - indexed for MEDLINE]
Free Article
14.

Outcome of combined interferon-ribavirin in the treatment of chronic hepatitis C.

Muhammad N, Jan MA, Rahman N.

J Coll Physicians Surg Pak. 2004 Nov;14(11):651-3.

PMID:
15530272
[PubMed - indexed for MEDLINE]
15.

[Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C].

Khalil A, Lucidarme D, Desurmont P, Hamdan-Khalil R, Filoche B.

Gastroenterol Clin Biol. 2005 Feb;29(2):193-6. Review. French.

PMID:
15795671
[PubMed - indexed for MEDLINE]
Free Article
16.

[Side effect of pegylated-interferon treatment in chronic C hepatitis: agranulocytosis].

Halász T, Farkas A, Tolvaj G, Horváth G.

Orv Hetil. 2006 Feb 19;147(7):321-4. Hungarian.

PMID:
17489160
[PubMed - indexed for MEDLINE]
17.

Daily interferon induction regimen using different manufactured interferons (alpha-2A or alpha-2B) in combination with ribavirin for treatment of chronic hepatitis C: a prospective randomized study.

Braga EL, Lyra AC, Nascimento L, Netto E, Kalabrik L, Lyra LG.

Arq Gastroenterol. 2006 Oct-Dec;43(4):275-9.

PMID:
17406754
[PubMed - indexed for MEDLINE]
Free Article
18.

Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment Group.

Shiffman ML, Hofmann CM, Gabbay J, Luketic VA, Sterling RK, Sanyal AJ, Contos MJ, Ryan MJ, Yoshida C, Rustgi V.

Am J Gastroenterol. 2000 Oct;95(10):2928-35.

PMID:
11051370
[PubMed - indexed for MEDLINE]
19.
20.

[Why is there a poor response to combined therapy with interferon alfa 2b and ribavirin in patients with chronic hepatitis C?].

Stránský J, Rýzlová M, Stríteský J, Nĕmecek V.

Cas Lek Cesk. 2002 Jun 7;141(11):351-4. Czech.

PMID:
12099059
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk